FLO-PRED Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Flo-pred, and when can generic versions of Flo-pred launch?

Flo-pred is a drug marketed by Taro and is included in one NDA. There is one patent protecting this drug.

This drug has eleven patent family members in nine countries.

The generic ingredient in FLO-PRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.

DrugPatentWatch^® Generic Entry Outlook for Flo-pred

Indicators of Generic Entry

< Available with Subscription >

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for FLO-PRED?
What are the global sales for FLO-PRED?
What is Average Wholesale Price for FLO-PRED?

Summary for FLO-PRED

International Patents:	11
US Patents:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	74
Patent Applications:	3,799
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for FLO-PRED
What excipients (inactive ingredients) are in FLO-PRED?	FLO-PRED excipients list
DailyMed Link:	FLO-PRED at DailyMed

Drug patent expirations by year for FLO-PRED

US Patents and Regulatory Information for FLO-PRED

FLO-PRED is protected by two US patents.

Patents protecting FLO-PRED

Oral suspension of prednisolone acetate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ASTHMA

Oral suspension of prednisolone acetate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF ALLERGIC REACTIONS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008		DISCN	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008		DISCN	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FLO-PRED

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	⤷ Sign Up	⤷ Sign Up
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	⤷ Sign Up	⤷ Sign Up
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FLO-PRED

See the table below for patents covering FLO-PRED around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	1909798	SUSPENSION ORALE D'ACETATE DE PREDNISOLONE (ORAL SUSPENSION OF PREDNISOLONE ACETATE)	⤷ Sign Up
Australia	5762894		⤷ Sign Up
European Patent Office	2008649		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Indicators of Generic Entry

AI Research Assistant

Questions you can ask:

Summary for FLO-PRED

Patents protecting FLO-PRED

Make Better Decisions: Try a trial or see plans & pricing